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Two nonribosomal peptide synthetases (NRPS),
NocA and NocB, together comprising five modules,
are essential for the biosynthesis of the D,L,D config-
ured tripeptide backbone of the monocyclic b-lac-
tam nocardicin A. We report a double replacement
gene strategy in which point mutations were engi-
neered in the two encoding NRPS genes without
disruption of the nocABC operon by placing selec-
tive markers in adjacent genes. A series of mutants
was constructed to inactivate the thiolation (T)
domain of each module and to evaluate an HHxxxDR
catalytic motif in NocA and an atypical extended
histidine motif in NocB. The loss of nocardicin A
production in each of the T domainmutants indicates
that all fivemodules are essential for its biosynthesis.
Conversely, production of nocardicin A was not
affected by mutation of the NocB histidine motif or
the R828G mutation in NocA.
INTRODUCTION
The biosynthesis of nocardicin A, isolated from the fermentation
of Nocardia uniformis subsp. tsuyamanensis, has been of
interest as the paradigm of a monocyclic b-lactam antibiotic
and for its activity against gram-negative bacteria and relative
stability to b-lactamases (Aoki et al., 1976; Hashimoto et al.,
1976; Kojo et al., 1988). Before discovery of the nocardicin A
gene cluster (Figure 1A), precursor incorporation studies have
shown that the D,L,D tripeptide backbone of this antibiotic family
originates from 2 units of L-p-hydroxyphenylglycine (L-pHPG)
and one unit of L-Ser (Townsend and Brown, 1983). A double-
label experiment demonstrated nocardicin G, a D,L,D tripeptide
b-lactam, to be the earliest isolable biosynthetic intermediate
of this pathway (Townsend and Brown, 1983; Townsend and
Wilson, 1988). On the basis of these early experiments and the
known structure of nocardicin G, the nocardicin A gene cluster
had been expected to encode a three module nonribosomal
peptide synthetase (NRPS), whose initiation and termination
modules installed D-pHPG into the peptide core by activation
and epimerization of L-pHPG and a central module that acti-
vated and incorporated L-serine to form the tripeptide core ofChemistry & Biology 19, 297the nocardicins. This expectation was founded on d-(L-a-amino-
adipyl-L-cysteinyl-D-valine (ACV) synthetase, the NRPS respon-
sible for biosynthesis of the immediate tripeptide precursor of
isopenicillin N, a fused bicyclic b-lactam, and one of the few
comparatively well-characterized NRPSs at the time. The 400-
425 kDa ACV synthetase had been isolated from both bacteria
and fungi and exemplified the classical ‘‘linear’’ NRPS architec-
ture depicted in Figure 2 (Martin, 2000). The order of adenylation
(A), thiolation (T) or peptidyl carrier, and condensation (C)
domains, along with a C-terminal epimerase (E) and thioesterase
(TE), fully accounted for synthesis of the Arnstein L,L,D-tripep-
tide. Also prior to characterization of the nocardicin gene cluster,
200 kDa and 150 kDa proteins that demonstrated ATP/PPi
exchange in the presence of L-pHPG were isolated from wild-
type N. uniformis. Fortuitously, the higher molecular weight
protein also exhibited ATP/PPi exchange in the presence of
L-serine (Gunsior et al., 2004), but reconstitution experiments
failed to produce nocardicin G. Against expectation, when the
nocardicin A gene cluster was discovered, it revealed two over-
lapping genes encoding a pair of NRPSs, nocA (11.1 kbp) and
nocB (5.8 kbp), which were predicted to translate a five-module
NRPS system and contained only a single epimerization domain
(Figure 1C) (Gunsior et al., 2004). The 200 kDa and 150 kDa
proteins isolated from wild-type N. uniformis were identified as
NocB and a proteolytic fragment of NocB, respectively—not of
NocA—in keeping with earlier failed reconstitution attempts.
A combination of in vitro, gene inactivation, and bioinformatic
experiments has been successfully applied to define the role of
each protein encoded in the nocardicin A gene cluster: nocF,
nocG, and nocN encode proteins responsible for the biosyn-
thesis of the nonproteinogenic amino acid precursor L-pHPG
(Figure 1B) (Gunsior et al., 2004); nat, nocJ, and nocL encode
proteins responsible for the late-stage biosynthetic steps—the
addition and epimerization of the homoseryl side chain and
oxime formation (Figure 1D) (Kelly and Townsend, 2002, 2004;
Reeve et al., 1998). NocR has been demonstrated to be a tran-
scriptional activator for the nocABC operon (Davidsen and
Townsend, 2009), NocI belongs to the MbtH family of proteins,
recently shown to be involved in activating A domains in some
NRPSs (Felnagle et al., 2010; Heemstra et al., 2009; Zhang
et al., 2010), and NocH is homologous to membrane transport
proteins of the major facilitator family (MFS) (Gunsior et al.,
2004). Proteins encoded by nocK, nocD, nocE, and nocO have
been shown by in vivo gene knockout experiments to be non-
essential for nocardicin A biosynthesis (Davidsen and Town-
send, 2009; Kelly and Townsend, 2005).–306, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 297
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Figure 1. Biosynthesis of Nocardicin A in N. uniformis
(A) Gene cluster for the biosynthetic pathway, which includes genes encoding two NRPSs (blue), tailoring enzymes (red), proteins involved in regulation and
transport (violet), proteins involved in biosynthesis of pHPG (green), and proteins shown to be nonessential for nocardicin A biosynthesis (gray).
(B) p-HPG biosynthetic pathway.
(C) Predicted domain and module organization of Noc A and NocB. Substrates predicted by bioinformatic analysis of the A domain active sites are shown.
(D) Late-stage biosynthetic steps; conversion of nocardicin G to nocardicin A.
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In Vivo Characterization of NRPSs NocA and NocBThe NRPSs of the gene cluster, NocA and NocB, are likely
responsible for the synthesis of the nonribosomal D,L,D-tripep-
tide core of nocardicin G based on A domain substrate predic-
tion algorithms consistent with the activation of L-pHPG by
modules 1, 3, and 5 and L-Ser by module 4 (Challis et al.,
2000; Gunsior et al., 2004). The substrate of the module 2 A
domain is less defined but has a signature suggesting L-N5-hy-
droxyornithine (Gunsior et al., 2004). Because of the gap in
biosynthetic logic between the five-module NRPS encoded in
the gene cluster and the requirement for a three-module NRPS
suggested by the structures of the isolated nocardicins, several
experiments were undertaken to further characterize the nocar-
dicin NPRSs. Unfortunately, attempts to heterologously express
NocA and NocB separately or partially as individual modules
in E. coli and Streptomyces for further in vitro analysis were
unsuccessful. Because of the high titer of nocardicin A produced
fromwild-type N. uniformis coupled with the successful isolation
of NocB and the expectation that NocA and NocB would be
translated in equal amounts from cotranscription of the nocABC
operon, the isolation of NocA from the native bacterium was
again pursued. However, despite assiduous attempts and the
re-isolation of NocB and its 150 kDa fragment, the 345 kDa
NocA protein was never observed.298 Chemistry & Biology 19, 297–306, February 24, 2012 ª2012 ElseIn the face of these setbacks, we returned to in vivo mutagen-
esis experiments to determine if NocA and/or NocB were essen-
tial for nocardicin A biosynthesis and, if so, to determine if they
function in a nonlinear manner either by using module skipping
or iterative logic. Because the genes encoding NocA, NocB,
and NocC (Nat) appear in a single operon, however, insertional
mutagenesis of nocA or nocB would likely affect transcription
of the downstream genes, automatically altering the production
of nocardicin A. Seeking precedents where the nocABC operon
would not be disrupted, it was found that in Streptomyces and
Bacillus subtilis double-gene replacement strategies to intro-
duce markerless targeted mutations into PKS or NRPS systems
have been successfully developed (Butz et al., 2008; Khosla
et al., 1992; Mootz et al., 2002a; Stachelhaus et al., 1995; Uguru
et al., 2004). Of particular relevance are module deletion, module
substitution methods, and module exchange experiments in
NRPS systems (Alexander et al., 2010; Baltz, 2009; Butz et al.,
2008; Khosla et al., 1992; Mootz et al., 2002a; Nguyen et al.,
2010; Powell et al., 2007; Stachelhaus et al., 1995; Uguru
et al., 2004).
In an extension of the genetic system previously developed
for insertional mutagenesis studies of N. uniformis (Kelly and
Townsend, 2005), described here are double replacementvier Ltd All rights reserved
Figure 2. Biosynthesis of the Arnstein L,L,D-Tripeptide, the Precursor to Isopenicillin N by ACV Synthetase
IPNS, isopenicillin N synthase.
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In Vivo Characterization of NRPSs NocA and NocBexperiments in which a dual function selection marker was used
in the second, ‘‘knock-in’’ step. A new strategy was devised that
can be particularly amenable to probing natural product biosyn-
thetic gene clusters and that takes advantage of the methods
developed for insertional mutagenesis experiments successfully
completed on genes nocF and nocE located adjacent to the no-
cABC operon. The preparation of 12 point mutants is presented,
which can be divided into three key areas of interest. First, is the
preparation of S to A point mutants for each T domain (total = 5)
of NocA and NocB. These experiments primarily test the hypoth-
esis that one or more modules of the NRPS is inactive. A second
experiment addresses the unusual HHxxxDR catalytic motif of
C2 of which the R residue is unexpected (Rausch et al., 2007).
An R828G point mutant was prepared to determine if this
unusual feature is critical for antibiotic production. Finally, an
atypical ‘‘extended His-motif,’’ reminiscent of that critical for
catalysis in C and E domains in NRPS systems, was noted in
the A5 domain of NocB. The third set of point mutants addressed
whether the residues of this motif play a role in the biosynthesis
of nocardicin A.
RESULTS AND DISCUSSION
Considerations for the Two-Step Gene Replacement
Experiment
Our goal was to develop an in vivo mutagenesis system for
N. uniformis for the preparation of markerless point mutants in
NocA and NocB, as was done for the Streptomyces and Bacillus
systems described earlier. Several blocked mutants of genes in
the nocardicin A cluster have been prepared in previous studies
in which an antibiotic cassette, tsr or apr, was inserted into the
gene of interest (Kelly and Townsend, 2005). The preparation
of an analogous N. uniformis insertional mutant is the first step
of the double replacement experiment. Protoplasts of wild-
type N. uniformis were prepared, transformed with a pULVK2
Nocardia-E.coli replicating shuttle vector, grown for several
rounds without selection, and successfully screened for homol-
ogous recombination mutants. However, the second step of the
double-gene replacement protocol proved more problematic
given the unavailability of a suicide or temperature-sensitive
plasmid compatible with N. uniformis of the type that was
successfully employed for gene replacements in Streptomyces
(Khosla et al., 1992). Initial studies in which a second pUVLK2
vector, engineered with a replacement sequence, transformedChemistry & Biology 19, 297into the knockout or deletion mutant, failed to undergo homolo-
gous recombination and produce the desired engineered
mutant. Further experimentation revealed the vector could not
be maintained without antibiotic selection.
Given the scarcity of plasmids available for Nocardia systems,
a gene replacement strategy was developed to incorporate
antibiotic selection markers in genes adjacent to the nocABC
operon. Previous studies had shown that the downstream genes
encoding NocD and NocE are not essential in nocardicin A
biosynthesis (Davidsen and Townsend, 2009). Upstream of the
NRPS operon, the nocA-nocF intergenic region is essential for
the binding of the pathway-specific transcriptional activator
NocR. The immediate upstream target, nocF, encodes a p-hy-
droxymandelate synthetase involved in the biosynthesis of the
pHPG precursor. Incorporation experiments in which isotopi-
cally labeled pHPG was added to fermentation cultures of
wild-type N. uniformis showed efficient incorporation into nocar-
dicin A (Townsend and Brown, 1983). Thus, it was anticipated
that insertional inactivation of nocF should be chemically com-
plemented by addition of pHPG to the fermentation medium.
A nocF::apr insertional inactivation mutant was prepared
and evaluated for antibiotic production. The culture superna-
tants of nocF::apr mutants confirmed by Southern analysis
were bioassayed against E. coli ESS and characterized by
high-pressure liquid chromatography (HPLC) analysis. Figure 3
compares chromatograms of the nocF::apr mutant with wild-
type N. uniformis. Nocardicin A (retention time = 14.6 min) was
not detected in the nocF::apr mutant but was substantially
restored by the addition of 0.5 mM L-pHPG to the fermentation
culture, as anticipated. Another notable difference between the
chromatograms of the wild-type and mutant is the minimal
depletion of tyrosine (retention time = 5 min) and absence of
p-hydroxybenzoyl formate (pHBF) accumulation (retention
time = 8.6 min) observed in the nocF::apr mutant growths. This
observation is consistent with previous studies of the pHPG
biosynthetic cycle (Figure 1B) (Hubbard et al., 2000; Mu¨ller
et al., 2006) However, the ability to restore nocardicin A produc-
tion in the nocF::apr N. uniformis mutant confirmed that this
insertional mutant could be efficiently chemically complemented
by fortification of the culture medium with L-pHPG.
The first step, therefore, involved the preparation of deletion
mutants T2KO and T3KO for targeted gene replacements in
nocA (Figure 4A) and T45KO for targeted gene replacements in
nocB (Figure 4B), in which the region between the location of–306, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 299
Figure 3. HPLC Chromatograms of the Culture Supernatants of
nocF::apr N. uniformiswith and without Chemical Complementation
with L-pHPG Compared to Wild-Type N. uniformis
Key components are tyrosine (retention time = 5 min), p-hydroxybenzoyl
formate (retention time = 8.6 min), and nocardicin A (retention time = 14.6 min),
indicated by a dot.
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In Vivo Characterization of NRPSs NocA and NocBthe apr cassette to be inserted in the second replacement step
and the NRPS domain of interest was deleted and replaced
with the tsr gene. As expected based on previous studies
(Gunsior et al., 2004), nocardicin A production was absent in
each of these deletion mutants. In preparation for the second
step, pULVK2 vectors were cloned containing nocF::apr-nocA
(Figure 4A) for nocA gene replacement studies or nocBC-apr-
nocE (Figure 4B) for nocB gene replacement studies. In both
cases, the pULVK2 knock-in vector encoded the gene, which
contained the apr resistance cassette, and the NRPS sequence
to at least 1,000 bp past the desired mutation. The step 1 dele-
tion mutants and the encoding of pULVK2 vectors for the
step 2 transformations were designed so that homologous
recombination would result in only one type of double crossover
mutant. The resulting mutant has the Aprr Tss phenotype and
encodes the engineered nocABC operon. This protocol allows
for the construction of NRPS mutants without disrupting the
regulatory elements of the gene cluster (Davidsen and Town-
send, 2009).
For each step 1 deletion mutant, a control knock-in mutant
was prepared, encoding the native sequence. Thus, successful
control experiments should result in the restoration of nocardicin
A production. The restoration of antibiotic production in all three
deletion mutants, T2KO, T3KO, and T45KO was observed by
replacement of the tsr cassette with their respective native
sequences of nocA or nocB, validating the strategy of the overall
experiment and providing additional evidence for accuracy in
the cloning of the pULVK2 vectors. In addition, because an apr
resistance marker disrupts nocF in T2KO and T3KO knock-in
experiments, antibiotic production should only be observable
in native knock-in mutants with the addition of pHPG to the
fermentation medium, a result that was observed in all the
control (native sequence) knock-in experiments. Although this
two-step gene replacement strategy requires a proximal nones-300 Chemistry & Biology 19, 297–306, February 24, 2012 ª2012 Elsesential or chemically complemented gene for placement of a
selection marker, it was attractive for several reasons but partic-
ularly because this method proved robust in producing the
desired engineered mutants and selecting for them using antibi-
otic sensitivity for the phenotype. After antibiotic selection, 1–4
putative mutants of each type were screened by Southern anal-
ysis, followed by sequence analysis. Mutants were identified and
confirmed from only one round of screening. This strategy
should be generally applicable to the investigation of other
natural product gene clusters.
Characterization of Mutants
To test the hypothesis that one or more modules of the NocA+
NocB NRPS system may be nonessential or skipped, we engi-
neered a serine-to-alanine mutation at the conserved phospho-
pantethienylation site of the T domain for each module and
prepared mutants using the double gene replacement strategy
outlined in Figure 4. Each of the resultingmutants was character-
ized for antibiotic production, as assessed by the E. coli ESS
bioassay and HPLC analysis for nocardicin A production. A
summary of results is shown in Table 1.
Although most NPRS systems are linear (i.e., the primary
sequence of the peptide product formed is colinear with the
ordered modules of its corresponding synthetase), there are
now a number of known ‘‘nonlinear,’’ Type C, NRPS systems
in which module skipping, iteration, or a combination of these
have been shown to occur in the formation of their peptide prod-
ucts (Haynes and Challis, 2007). Based on the hypothesis that
the D,L,D- configured tripeptide backbone of nocardicin G orig-
inates from NocA + NocB, the nocardicin NRPS system was
classified as a nonlinear Type C NRPS (Mootz et al., 2002b).
Furthermore, within modules 1 and 2 were noted several atypical
regions in which additional sequences of short amino acid
repeats were found, leading to the hypothesis that perhaps
modules 1 and 2 were skipped or inactive and, thus, the three
remaining modules were responsible for the biosynthesis of
D-pHPG-L-Ser-D-pHPG (Gunsior et al., 2004). Evidence for
module skipping due to a defective T domain in which the
conserved active site serine is not located in the expected posi-
tion was reported in myxochromide biosynthesis in Stigmatella
aurantica. As a consequence, proline is not incorporated into
the peptide chain, despite an active A domain (Wenzel et al.,
2005, 2006).
However, contrary to this hypothesis, antibiotic production
was not detected in any of the T domain point mutants. Figures
5A–5C shows the chromatograms of the culture supernatants for
each mutant, comparing them to the chromatograms of their
respective first-step deletion mutant, positive control, and
wild-type N. unformis. Figures 5A and 5B plot chromatograms
for the nocA T1PM (S626A), T2PM (S1671A), and T3PM
(S2782A) mutants and reveal few distinctions between the
T1PM, T2PM, and T3PM point mutants and their parent T2KO
and T3KO deletion mutants, each grown in culture medium sup-
plemented with 0.5 mM L-pHPG. Chromatograms for nocB
T4PM (S571A) and T5PM (S1648A) are plotted in Figure 5D.
Again, the chromatograms of T4PM and T5PM lack a peak for
nocardicin A and resemble the chromatograms of their parent
T45KO deletion mutant. Because the apr resistance marker in
the second step of the nocB gene replacement is located atvier Ltd All rights reserved
Figure 4. In Vivo Two-Step Gene Replacement
Strategy
The first step required the preparation of a deletion
mutant. Transformation of the deletion mutant with a
vector containing the native or engineered sequence fol-
lowed by homologous recombination gives the desired
mutant.
(A) Strategy for mutagenesis of nocA, in which an apr
gene cassette is placed in the adjacent gene nocF. The
nocF::apr mutant is chemically complemented by the
addition of L-pHPG to the culture medium.
(B) Strategy for mutagenesis of nocB, in which an apr gene
cassette is placed in the nonessential gene nocE.
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In Vivo Characterization of NRPSs NocA and NocBthe end of the gene cluster and, thus, does not perturb pHPG
biosynthesis, the depletion of tyrosine and the accumulation of
HBF are observed in these mutants. In addition, no new peaks
that might correspond to NRPS derailment products were seen
in the HPLC chromatograms of the T-domain mutants. In all
cases, control experiments in which native sequences were
restored to the T2KO, T3KO, and T45KO deletion mutants
demonstrated significant restoration of nocardicin A production,
unlike the T-domain mutants, indicating that each of the five
modules of this NRPS is essential for nocardicin A biosynthesis.
Mutagenesis of the nocA C2 domain was prepared to deter-
mine whether replacement of the arginine from the unusual cata-
lytic motif HHxxxDR to the consensus HHxxxDG would affect
nocardicin A production. The canonical catalytic motif of C
domains is HHxxxDG, also called the ‘‘His motif’’ (Rausch
et al., 2007). Mutagenic studies on the N-terminal C domain ofChemistry & Biology 19, 297–306, February 24TycB (tyrocidine) showed that the second histi-
dine and aspartate residues of this signature
are essential for C domain activity (Bergendahl
et al., 2002; Stachelhaus et al., 1998), but there
is conflicting evidence as to whether the
terminal glycine of this motif is also essential.
Although the HHxxxDR motif is also found in
the C13 domain of daptomycin synthetase,
catalyzing the addition of L-kynurenine to the
nascent peptide in S. roseosporus (Miao et al.,
2005), studies on the C domain of EntF (entero-
bactin) found the terminal G residue of the
HHxxxDG motif to be essential. When a G-to-L
mutation was introduced, it abolished activity,
which was thought to result from steric occlu-
sion of the substrate channel (Roche andWalsh,
2003). This observation posed the question
whether the arginine residue of the HHxxxDR
motif in C2 might render this domain inactive
and block transfer of the growing peptide from
the first two modules to the third. A precedent
for the presence of an inactive C domain that
is compensated for by the next downstream
active C domain has been observed in bleomy-
cin biosynthesis (Du et al., 2003). The nocA
R828G mutant was found to retain antibiotic
production (Table 1). Based on HPLC analyses
of the culture supernatant of this mutant (Fig-
ure 5C), this mutation also did not result in adifference in nocardicin A production compared to the native
control, and no new peaks were observed. This result is consis-
tent with the structural analysis of the TycC6 C domain (Samel
et al., 2007), in which the second H residue is catalytic and the
D residue is essential for providing interactions that stabilize
the active site. In the crystal structure, a sulfate ion sits in the
active site and is ‘‘presumed’’ to be situated to mimic the thiol
terminus of the pantethienyl moiety. This sulfate is hydrogen
bonded to the peptide backbone at the G residue, suggesting
that the side chain of the amino acid residue at this position is
not critical and thus less conserved.
The observation that each of the five T domains is required for
nocardicin A biosynthesis allows us to draw several conclusions.
First, this study demonstrates that both NocA and NocB are
essential for nocardicin biosynthesis, and there is no evidence
that module skipping occurs in this NRPSs system. This was, 2012 ª2012 Elsevier Ltd All rights reserved 301







Wild-type None 280 +
T2KO DnocF-DnocA (M1-2)::tsr 0 
Control/T2KI nocF::apr 50 +
T1PM nocF::apr; nocA S626A 0 
T2PM nocF::apr; nocA S1671A 0 
C2PM nocF::apr; nocA R828G 37 +
Control/T3KI nocF::apr 33 +
T3KO DnocF-DnocA (M1-3)::tsr 0 
T3PM nocF::apr; nocA S2782A 0 
T45KO DnocBCDE::tsr 0 
Control/T45KI nocE, apr 106 +
T4PM nocB S571A 0 
T5PM nocB S1648A 0 
M3-4 nocB H1411A 81 +
M4-8 nocB H1412A 65 +
M6-2 nocB E1417A 104 +
M7-2 nocB D1418A 54 +
See also Figure S1.
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In Vivo Characterization of NRPSs NocA and NocBunexpected. The absence of wild-type NocA, but the compara-
tively ready isolation of NocB, led us to suspect that the former
was swiftly proteolyzed, as was clearly observed for NocB, to
smaller fragments that might act in trans. It was hypothesized
that the unusual repeated sequences inserted after A1 and
before module 3, for example, presented vulnerable sites where
just such events could take place. Our observations make it less
likely that a proteolytic product of NocA or NocB is acting in trans
with NocB to produce a tripeptide. The other possibility previ-
ously entertained was that NocA was not essential and that an
alternate starting module existed, as in anabaenopeptin biosyn-
thesis in Anabaena (Rouhiainen et al., 2010), encoded in a yet
unknown gene cluster but capable of crosstalking with the no-
cardicin gene cluster. Crosstalk between gene clusters has
been observed in the biosynthesis of erythrochelin (Lazos
et al., 2010; Robbel et al., 2011) and rhodochelin (Bosello
et al., 2011).
There are several known examples of NRPSs with ‘‘too many
modules.’’ The exochelin gene cluster in Mycobacterium
smegmatis encodes a six-module NRPS; however, exochelin is
a pentapeptide. Whether all six modules are essential for exo-
chelin biosynthesis is not known (Yu et al., 1998). Thiocoraline
biosynthesis inMicromonospora is another system that appears
to involve extra modules. The thiocoraline gene cluster encodes
four NRPSs—TioR, TioS, TioY, and TioZ—of which, the roles of
TioY and TioZ are unclear. Although it appears that only TioR and
TioS should be required for the biosynthesis of the peptide
precursor, in vivo mutagenesis experiments conclude that TioY
and TioZ are also essential for thiocoraline biosynthesis (Lombo´
et al., 2006). A third example is the tandem TE domains that
terminate the NRPSs involved in lysobactin, arthrofactin, masse-302 Chemistry & Biology 19, 297–306, February 24, 2012 ª2012 Elsetolide, and syringopeptin biosyntheses. In vivo studies of the
arthrofactin system showed both TE domains to be involved in
efficient product formation (Roongsawang et al., 2007). Recent
in vitro studies of the terminal module of the lysobactin NRPS
demonstrated proteolytic cleavage of the terminal TE domain,
leading the authors to propose that the terminal TE domain is
also proteolyzed from the NRPS in the native Lysobacter to
then function as an editing stand-alone type II TE domain (Hou
et al., 2011).
The combination of bioinformatic analysis of the nocardicin A
gene cluster, particularly the NRPS proteins NocA and NocB, as
well as characterization of the in vivo NocA and NocB point
mutants, indicate the likelihood that NocA+NocB is forming a
pentapeptide or a pentapeptide b-lactam. If the NocA+NocB
product is a pentapeptide, how and at what point in the pathway
is it trimmed to a tripeptide? There are natural products with a
closely related, inactive biosynthetic precursor that can be
accumulated in the host until an appropriate time for release.
In lantibiotic biosynthesis, the leader peptide has been proposed
to act as an in-cis chaperone for posttranslational modification
enzymes or a provider of stabilizing interactions that prevent
degradation and assist in folding of the precursor peptide
(Oman and van der Donk, 2010). In Pseudomonas syringae, the
dipeptide precursor of tabtoxin, tabtoxinine-b-lactam, is
trimmed by a periplasmic aminopeptidase encoded in the
gene cluster to activate the b-lactam product (Kinscherf and
Willis, 2005; Levi and Durbin, 1986). Because of the absence of
a specifically encoded protease in the nocardicin cluster, the
possibility that M2 might append a moiety such as N5-hydrox-
yornithine or ornithine, and that cleavage of the first two residues
might be autocatalytic, has been considered (Gunsior et al.,
2004).
Another anomaly of nocardicin A biosynthesis considered in
this study is the conversion of L-pHPG to its D antipode at two
centers in nocardicin A when only one epimerase is found in its
synthetase. D-amino acids are usually incorporated into nonri-
bosomal products by the action of an epimerization domain,
located immediately downstream of the T domain in a typical
NRPSmodule, as seen in module 3 of NocA (Linne andMarahiel,
2000). Only rarely are D-amino acids substrates for direct activa-
tion by A domains in NRPSs, although cyclosporin, fusaricidin,
and leinamycin synthetases have been shown to activate
D-alanine for direct incorporation into the product peptide
(Hoffmann et al., 1994; Li and Jensen, 2008; Tang et al., 2007;
Zocher et al., 1986). An alanine racemase, located in the cyclo-
sporin gene cluster, has been characterized, whereas the fusar-
icidin and leinamycin gene clusters do not appear to contain
a similar racemase (Hoffmann et al., 1994; Li and Jensen,
2008). A third strategy for the addition of D-amino acids into
nonribosomal products involves action of C domains that also
catalyze epimerase activity. These dual C/E domains are
observed in arthrofactin, syringomycin, syringopeptin, and ra-
moplanin synthetases (Balibar et al., 2005) and are characterized
by an extended histidine sequence at the N terminus, HH(I/L)
xxxxDG, in addition to the conventional His motif (HHxxxDG)
known to be essential for condensation of the peptide bond.
A fourth, and thus far unique, example for epimerization has
been found in the PchE protein of pyochelin synthetase.
Between the A8 and A9 motifs of the cysteine-activating Avier Ltd All rights reserved
Figure 5. HPLC Chromatograms of the
Culture Supernatants from Each Set of
N. uniformisMutants Prepared in This Study
Compared to Wild-Type, Analyzed after
Fermentation for 5 Days
In these studies, the culture medium was supple-
mented with 0.5 mML-pHPG, except where noted
otherwise. The peak for nocardicin A is indicated
by a dashed line.
(A) Chromatograms for deletion mutant T2KO, T
domain mutants nocA S626A (T1PM) and nocA
S1671A (T2PM), and the native knock-in experi-
ment (represented as (+) Cntl), in which the native
nocA sequence was restored.
(B) Chromatograms for deletion mutant T3KO, T
domain mutant nocA S2782A (T3PM), and a posi-
tive control (represented as (+) Cntl), in which the
native nocA sequence was restored compared to
wild-type N. unformis.
(C) Chromatograms for mutant nocA R828G,
located in the C2 domain are compared to the
deletion mutant T2KO and wild-type N. unformis.
For comparison, the chromatogram of the C2PM
mutant, grown without pHPG supplementation, is
shown.
(D) Chromatograms for deletion mutant T45KO, T
domain mutants nocB S571A (T4PM) and nocB
S1648A (T5PM), and a positive control (repre-
sented as (+) Cntl), in which the native nocB
sequence was restored, are plotted.
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In Vivo Characterization of NRPSs NocA and NocBdomain exists an approximately 300-amino-acid insert resem-
bling a methyltransferase domain. However, mutagenesis of
histidine 1204 to alanine was shown to eliminate racemization
of the tethered benzoylcysteine intermediate, suggesting that
this insert functions as an epimerization domain (Patel et al.,
2003).
Because of the absence of a second E domain, a dual C/E
domain or a racemase in the gene cluster and the pyochelin
precedent, the discovery of an extended histidine motif,
HHTCAPEDG, between Motifs A5 and A6 of the A5 domain
posed the question of whether this could be an epimerization
motif. In addition, the lack of epimerization domains in the initia-
tion modules of several glycopeptides was of interest (Sosio
and Donadio, 2006). Alignment of the A1 domains of chloroere-
momycin, balhimycin, A47934, complestatin, and teicoplanin
synthetases shows conservation at the second histidine and
aspartate residues, which correspond to the catalytic residues
of epimerization motifs. (Figure 6) All the mutants prepared in
the A5 domain—H1411A, H1412A, E1417A, and D1418A—
produced nocardicin A at levels virtually unchanged compared
to that of the native control (Table 1; Figure S1 available online),
indicating that this motif is not essential for formation of the
peptide precursor and thus is unlikely to be involved in an
epimerization reaction.
Several hypotheses can account for conversion from the L- to
the D-antipode of the C-terminal pHPG in nocardicin A biosyn-Chemistry & Biology 19, 297–306, February 24, 2012thesis. The possibility that this activity
is cryptically embedded in nocardicin
synthetase has not been eliminated.
Second, a racemase encoded outsidethe known gene cluster may have a role. Other than D-Ala and
D-Glu, known components of bacterial peptidoglycan, other
D-amino acids have been found in a variety of prokaryotes, along
with the discovery of a broad-spectrum racemase (Lam et al.,
2009). Finally, synthetic studies have shown the C5 position to
be base labile, suggesting that epimerization at C5 might occur
in tandem with amide deprotonation and b-lactam formation
(Salituro and Townsend, 1990).
SIGNIFICANCE
Two NRPS enzymes, NocA and NocB, act centrally in the
biosynthesis of the nocardicin monocyclic b-lactam antibi-
otics. Bioinformatic comparisons of these proteins reveal
several anomalies as, for example, extended repeat se-
quences and atypical histidine motifs that call into question
whether these multidomain enzymes are conventionally
functional, particularly modules 1 and 2 of NocA, and what
their roles are in the biosynthesis. While NocA and NocB
comprisefivemodules, the last threewouldappear sufficient
to generate the tripeptide core of this antibiotic family. In
beginning to answer these questions, we found that expres-
sion of these peptide synthetases in Escherichia coli and
Streptomyces hosts proved intractable. A two-step, in vivo
gene replacement strategy reported here enabled the prepa-
ration of a series of point mutants to evaluate the roles ofª2012 Elsevier Ltd All rights reserved 303
Figure 6. Comparison of Extended His Motif Observed in the NocB
A5 Domain to the Initiation A Domains of NRPSs for Chloroeremo-
mycin, Balhimycin, Complestatin, A47934, and Teicoplanin
Identical residues are shaded. The conserved histidine and acidic residues of
the extended His motif are noted with an asterisk. Numbers indicate amino
acid residues from the N terminus of the protein. Gene Bank accession
numbers are as follows: chloroeremomycin (CepA), AJ223999; balhimycin
(BpsA), Y16952; complestatin (ComA), AF386507; A47934 (StaA), U82965;
and teicoplanin (TcpA), AJ605139.
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In Vivo Characterization of NRPSs NocA and NocBindividual residues and modules in NocA+NocB without
disruption of promoter or regulatory elements. The use of
chemical complementation of an ancillary precursor biosyn-
thetic gene in the critical second ‘‘knock-in’’ step proved to
be robust and reliable andmay bemorewidely useful in anal-
ogous studies of natural product biosynthetic pathways.
Using this method the phosphopantethiene attachment site
in each of the five T domains was specifically mutated to
alanine and, in each instance, proved essential to antibiotic
production. An uncommon HHxxxDR catalytic motif in C2
was mutated to the canonical HHxxxDG, but both were
equivalently active in nocardicin A biosynthesis. A similar
extended His motif in A5, potentially responsible for the
cryptic C-terminal epimerization characteristic of all known
nocardicins, was unaffected by mutation. These data
suggest that all modules of NocA and NocB are required
for nocardicin G synthesis that and these unusually modified
proteins, in fact, appear to function normally. Their interplay
is now more sharply defined, but more complex questions
remain in the full orchestration of precursor peptide
assembly, editing, C-terminal epimerization, and b-lactam
formation.EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmid Construction
Strains and plasmids and oligonucleotide primers used in PCR amplification
and Quick Change reactions are included in the Supplemental Information.
We performed PCR amplification reactions using previously prepared cosmid
or plasmid templates with Pfu (Stratagene, LaJolla, CA) DNA polymerase and
using primers purchased from IDT-DNA (Coralville, IA). Amplified products
were typically subcloned into pT7B3 (EMD Biosciences, Gibbstown, NJ) or
pUC19 using standard protocols. We performed further manipulation of DNA
for plasmid preparation using standard procedures (Maniatis et al., 1982).
Point mutations were engineered into plasmids of interest using Quick-
Change (Stratagene) (Weiner and Costa, 1995). DNA polymerases Pfu Ultra
or Pfu Turbo (Stratagene) were used combined with a manual ‘‘hot start’’
PCR amplification protocol. Following PCR, products were treated with Dpn
I to remove template DNA. DNA was concentrated using Pellet Paint (EMD
Biosciences) before transformation into E. coli XL1-Blue by electroporation.
The construction of all plasmids was confirmed by DNA sequencing at the
Biosynthesis and Sequencing Facility, Johns Hopkins Medical School, Balti-
more MD.304 Chemistry & Biology 19, 297–306, February 24, 2012 ª2012 ElseCulture and Assay Conditions
Nocardia uniformis subsp. tsuyamanesis ATCC 21806 (wild-type strain),
producer of the antibiotic nocardicin A, was maintained on ISP2 solid medium
(Difco Laboratories, Detroit, MI) at 28C. Seed cultures were prepared in trypic
soy broth (TSB) medium (Difco Laboratories) and incubated at 28C, with
shaking, for inoculation of fermentation medium (containing, per liter, 10 g
peptone, 4 g yeast extract, 10 g KH2PO4, 4 g NaH2PO4, 2.4 g MgSO4, 2 g
glycine, 2 ml trace minerals, 20 g soluble starch, 1 g tyrosine, and 75 mg
L-methionine) as previously described (Reeve et al., 1998). During the 5- to
7-day growth period for N. uniformis, aliquots of the culture supernatants
were sampled and assayed for the production of nocardicin A and related
precursors by bioassay versus E. coli ESS and quantitative HPLC. Culture
aliquots were centrifuged to separate the cell mass from the supernatant,
and both were stored at 20C. A paper disc bioassay analysis to detect
antibiotic production was prepared by the application of 200 ml of culture
supernatant to paper discs placed on solid Luria broth medium inoculated
with E. coli ESS. Plates were analyzed for developed zones of antibiosis after
incubation at 37C overnight. We performed quantitative analyses of nocardi-
cin A production using an Agilent 1100 HPLC system equipped with a diode
array detector. Filtered supernatants (nylon, 0.45 mm) were injected directly
on to a Luna C18(2) column (250 mm 3 46 mm) (Phenomenex, Torrance,
CA), using an isocratic mobile phase: 90:10 water:acetonitrile with 0.08%
trifluoroacetic acid at a flow rate of 1ml/min. Analytes were detected by absor-
bance at 272 nm and were quantified by comparison to a standard curve.
Protoplast Transformation of N. uniformis and Preparation
of Mutants
Before protoplast transformation into N. uniformis, the constructed pULVK2
(Nocardia–E.coli) shuttle vectors were transformed into E. coli JM110 cells to
provide nonmethylated DNA. The protocol for PEG-mediated transformation
of N. uniformis with pULVK2 vectors has been described previously (Kelly and
Townsend, 2005). N. uniformis pULVK2 vector transformants were selected
by a 200 mg/ml kanamycin and 100 mg/ml apramycin or 25 mg/ml thiostreptone
overlay. The Aprr Kanr or TSr Kanr phenotype was confirmed by plating on ISP2
solid medium containing 200 mg/ml kanamycin and 100 mg/ml apramycin or
25 mg/ml thiostreptone. Transformants were usually subjected to three rounds
of nonselective plating on ISP2 to obtain double crossover mutants. However,
selective propagation on ISP2, using 100 mg/ml apramycin, was used after
the transformation of the T2KO, T3KO, and T45KOmutant N. uniformis strains.
Putativedouble crossovermutantswere identifiedby their predictedphenotype
and confirmed by Southern analysis and sequencing of genomic DNA.
Plasmid Construction for nocF::apr Disruption Mutant
The nocF gene (1,035 bp)was amplified using primers nocF_For and nocF_Rev
and subcloned into pT7B3 (EMD Biosciences). The resulting pT7B3/nocF
plasmid was linearized by digestion with Bbs I and blunted with Klenow. The
apr insert was prepared by digestion from plasmid pT7B3/apr and ligated
into the linearized nocF plasmid. The disrupted gene cassette nocF::apr (3.1
kbp) was ligated into the EcoR I site of pULVK2 to generate pULVK2/nocF::apr.
Plasmid Construction for Two-StepGene Replacement Experiments
Detailed procedures for the cloning of plasmids for both the step 1 deletion
mutants and the step 2 knock-in mutants are described in the Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.chembiol.
2011.10.020.
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